MedTrace Logo

New Topical Treatment for Continued Pain After Shingles

NCT00566904 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-08-31

No results posted yet for this study

Summary

Shingles is an outbreak of rash or blisters on the skin that is caused by the same virus that causes chicken pox. Some people experience continued pain even after the shingles rash and blisters have healed; this pain is known as postherpetic neuralgia. The purpose of this study is to evaluate the effectiveness of a new topical treatment for postherpetic neuralgia in adults.

Conditions

  • Postherpetic Neuralgia

Interventions

DRUG

Epikeia coatings with aspirin

Applied to affected skin area using a roll-on ball applicator

DRUG

Epikeia coatings with lidocaine

Applied to affected skin area using a roll-on ball applicator

OTHER

Epikeia coatings alone

Applied to affected skin area using a roll-on ball applicator

Sponsors & Collaborators

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • The University of Texas Health Science Center, Houston

    collaborator OTHER

  • Biomedical Development Corporation

    lead INDUSTRY

Principal Investigators

  • Adelaide A. Hebert, MD · The University of Texas Health Science Center, Houston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2008-08-31
Completion
2008-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00566904 on ClinicalTrials.gov